Evidence map›Paper›PMID 25708609›Full record

ArticleToxicology and applied pharmacology2015

Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.

Xi Yang, William F Salminen, Qiang Shi, James Greenhaw, Pritmohinder S Gill, Sudeepa Bhattacharyya, Richard D Beger, Donna L Mendrick, William B Mattes, Laura P James

Open access · hybridAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. miR-375 protects against acetaminophen-induced acute liver failure by orchestrating pharmacogene expression.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Acetaminophen Hepatotoxicity.Seminars in liver disease · 2019
    Article
  12. Biomarkers of drug-induced liver injury.Advances in pharmacology (San Diego, Calif.) · 2019
    Review
  13. Review
  14. Article
  15. Review
  16. Overview of microRNA Modulation in Analgesic Research.Current protocols in pharmacology · 2017
    Review
  17. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2017
    Review
  18. Article
  19. The transformation in biomarker detection and management of drug-induced liver injury.Liver international : official journal of the International Association for the Study of the Liver · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xi YangDivision of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, USA. Electronic address: Xi.Yang@fda.hhs.gov.
William F SalminenDivision of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, USA. Electronic address: Willie.Salminen@parexel.com.
Qiang ShiDivision of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, USA. Electronic address: Qiang.Shi@fda.hhs.gov.
James GreenhawDivision of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, USA. Electronic address: James.Greenhaw@fda.hhs.gov.
Pritmohinder S GillDepartment of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Clinical Pharmacology and Toxicology Section, Arkansas Children's Hospital, Little Rock, AR, USA. Electronic address: PSGill@uams.edu.
Sudeepa BhattacharyyaDepartment of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Clinical Pharmacology and Toxicology Section, Arkansas Children's Hospital, Little Rock, AR, USA. Electronic address: SBhattacharyya2@uams.edu.
Richard D BegerDivision of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, USA. Electronic address: Richard.Beger@fda.hhs.gov.
Donna L MendrickDivision of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, USA. Electronic address: Donna.Mendrick@fda.hhs.gov.
William B MattesDivision of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, USA. Electronic address: William.Mattes@fda.hhs.gov.
Laura P JamesDepartment of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Clinical Pharmacology and Toxicology Section, Arkansas Children's Hospital, Little Rock, AR, USA. Electronic address: jameslaurap@uams.edu.
National Center for Toxicological Research · USArkansas Children's Hospital · USUniversity of Arkansas for Medical Sciences · US

Funding

Identification of new mechanistic biomarkers of adverse responses to acetaminopheR01DK081406 · NIDDK · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI JAMES, LAURA P · 2009 to 2013
$1.9M
HIF-1alpha and VEGF in Acetaminophen Toxicity and RepairR01DK075936 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2007 to 2011
$1.3M
NIDDK NIH HHS R01 DK075936NIDDK NIH HHS R01 DK081406NIDDK NIH HHS R01 DK75936
6 · The paper itself

Abstract

unlabelledDeveloping biomarkers for detecting acetaminophen (APAP) toxicity has been widely investigated. Recent studies of adults with APAP-induced liver injury have reported human serum microRNA-122 (miR-122) as a novel biomarker of APAP-induced liver injury. The goal of this study was to examine extracellular microRNAs (miRNAs) as potential biomarkers for APAP liver injury in children. Global levels of serum and urine miRNAs were examined in three pediatric subgroups: 1) healthy children (n=10), 2) hospitalized children receiving therapeutic doses of APAP (n=10) and 3) children hospitalized for APAP overdose (n=8). Out of 147 miRNAs detected in the APAP overdose group, eight showed significantly increased median levels in serum (miR-122, -375, -423-5p, -30d-5p, -125b-5p, -4732-5p, -204-5p, and -574-3p), compared to the other groups. Analysis of urine samples from the same patients had significantly increased median levels of four miRNAs (miR-375, -940, -9-3p and -302a) compared to the other groups. Importantly, correlation of peak serum APAP protein adduct levels (an indicator of the oxidation of APAP to the reactive metabolite N-acetyl-para-quinone imine) with peak miRNA levels showed that the highest correlation was observed for serum miR-122 (R=0.94; p<0.01) followed by miR-375 (R=0.70; p=0.05).

conclusionOur findings demonstrate that miRNAs are increased in children with APAP toxicity and correlate with APAP protein adducts, suggesting a potential role as biomarkers of APAP toxicity.

Indexed as

AcetaminophenAdolescentBiomarkersChemical and Drug Induced Liver InjuryChildChild, PreschoolDrug OverdoseFemaleHumansLiverMaleMicroRNAsAcetaminophenBiomarkersMicroRNAsAcetaminophenDILIMicroRNAPediatricUrine

Identifiers

PMID25708609
PMCPMC4558622
OpenAlexW1971179905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.